JP2004517630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517630A5 JP2004517630A5 JP2002558463A JP2002558463A JP2004517630A5 JP 2004517630 A5 JP2004517630 A5 JP 2004517630A5 JP 2002558463 A JP2002558463 A JP 2002558463A JP 2002558463 A JP2002558463 A JP 2002558463A JP 2004517630 A5 JP2004517630 A5 JP 2004517630A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense compound
- antisense
- src
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/723,535 US6355483B1 (en) | 2000-11-27 | 2000-11-27 | Antisenses inhibition of SRC-2 expression |
| PCT/US2001/044216 WO2002057409A2 (en) | 2000-11-27 | 2001-11-26 | Antisense modulation of src-2 expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517630A JP2004517630A (ja) | 2004-06-17 |
| JP2004517630A5 true JP2004517630A5 (https=) | 2005-05-19 |
Family
ID=24906673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002558463A Withdrawn JP2004517630A (ja) | 2000-11-27 | 2001-11-26 | Ｓｒｃ−２発現のアンチセンスモジュレーション |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6355483B1 (https=) |
| EP (1) | EP1346065A2 (https=) |
| JP (1) | JP2004517630A (https=) |
| AU (1) | AU2002245030A1 (https=) |
| WO (1) | WO2002057409A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355483B1 (en) * | 2000-11-27 | 2002-03-12 | Isis Pharmaceuticals, Inc. | Antisenses inhibition of SRC-2 expression |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
| US5734039A (en) * | 1994-09-15 | 1998-03-31 | Thomas Jefferson University | Antisense oligonucleotides targeting cooperating oncogenes |
| US6268173B1 (en) * | 1996-07-12 | 2001-07-31 | Institut Natural De La Sante Et La Recherche Medicale | Polynucleotide encoding transcriptional intermediary factor-2 |
| WO1998056806A1 (en) * | 1997-06-12 | 1998-12-17 | The Regents Of The University Of California | A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP |
| US5951455A (en) * | 1998-12-04 | 1999-09-14 | Isis Pharmaceuticals, Inc. | Antisense modulation of G-alpha-11 expression |
| US6355483B1 (en) * | 2000-11-27 | 2002-03-12 | Isis Pharmaceuticals, Inc. | Antisenses inhibition of SRC-2 expression |
-
2000
- 2000-11-27 US US09/723,535 patent/US6355483B1/en not_active Expired - Lifetime
-
2001
- 2001-11-26 AU AU2002245030A patent/AU2002245030A1/en not_active Abandoned
- 2001-11-26 JP JP2002558463A patent/JP2004517630A/ja not_active Withdrawn
- 2001-11-26 EP EP01993172A patent/EP1346065A2/en not_active Withdrawn
- 2001-11-26 WO PCT/US2001/044216 patent/WO2002057409A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004513626A5 (https=) | ||
| JP2004509619A5 (https=) | ||
| CA2397590A1 (en) | Antisense inhibition of ptp1b expression | |
| JP2003523739A5 (https=) | ||
| JP6047270B2 (ja) | Ｄｎａリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段 | |
| JP2005520489A5 (https=) | ||
| RU2501803C2 (ru) | Композиции и способы модуляции экспрессии рецептора фактора роста фибробластов 4 (fgfr4) | |
| CA2451643A1 (en) | Antisense modulation of superoxide dismutase 1, soluble expression | |
| JP2012050438A5 (https=) | ||
| JP2018150344A5 (https=) | ||
| JP2009508527A5 (https=) | ||
| JP2010539950A5 (https=) | ||
| WO2015193651A4 (en) | Reducing intron retention | |
| JP2005503142A5 (https=) | ||
| CA2343102A1 (en) | Antisense modulation of survivin expression | |
| JP2012508560A5 (https=) | ||
| JP2016530882A5 (https=) | ||
| JP2010505432A5 (https=) | ||
| JP2004503232A5 (https=) | ||
| KR20150004414A (ko) | Kras-관련 질환을 치료하기 위한 유기 조성물 | |
| WO2001066597A3 (en) | Inflammation-related gene | |
| TW202304474A (zh) | 用於抑制晚期糖化終產物之受體表現之RNAi藥劑、其組合物及使用方法 | |
| CA2389036A1 (en) | Antisense modulation of integrin-linked kinase expression | |
| CN112996913A (zh) | 寡聚核酸分子及其应用 | |
| WO2023134705A1 (zh) | 抑制angptl3表达的rna干扰剂及其用途 |